CDKN2A and neoplasm: We found that in three of the four cases with low CDKN2A mRNA expression but strong p16 protein staining, the tumor harbors either PIK3CA mutation, PIK3CB amplification or loss of PTEN gene (Table S2, case B6, NB7, NB8).